Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice.
The P2X7 receptor is a member of the family of P2X purinergic receptors, which upon sustained activation forms large pores in the plasma membrane. In cells of hematopoietic origin, P2X7 receptor activation has been shown to lead to multiple downstream events, including cytokine release, cell permeabilization, and apoptosis. This receptor has also been implicated in the generation of multinucleated giant cells, polykaryons, and osteoclasts. We have recently demonstrated that a blockade of this receptor inhibits osteoclast formation in vitro; therefore, we examined mice deficient in the P2X7 receptor in the context of bone. These mice were healthy and displayed no overt skeletal problems. Furthermore, we were able to demonstrate their ability to form multinucleated cells, in particular osteoclasts, both in vivo and in vitro. We also demonstrate the ability of P2X7R-/- multinucleated osteoclasts, upon stimulation with maitotoxin (MTX), to form pores in the plasma membrane in vitro. These findings are consistent with the existence of an endogenous pore structure present in osteoclast precursor cells that can be activated either by the P2X7 receptor, or in its absence, by alternative signals to mediate fusion and pore formation. These data provide further insight into the mode of action of the P2X7 receptor.
Gartland
A
A
Department of Cell Biology, University of Massachusetts Medical School, 55 Lake Avenue N., Worcester, MA 01655, USA. Alison.Gartland@umassmed.edu
Buckley
K A
KA
Hipskind
R A
RA
Perry
M J
MJ
Tobias
J H
JH
Buell
G
G
Chessell
I
I
Bowler
W B
WB
Gallagher
J A
JA
D000818:Animals; D017209:Apoptosis; D015139:Blotting, Southern; D002459:Cell Fusion; D002462:Cell Membrane / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D003720:Densitometry; D004996:Ethidium / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000494:pharmacology; D005838:Genotype; D066298:In Vitro Techniques; D008387:Marine Toxins / Q000494:pharmacology; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D010010:Osteoclasts / Q000378:metabolism*; D035964:Oxocins / Q000494:pharmacology; D010641:Phenotype; D018048:Receptors, Purinergic P2 / Q000235:genetics* / Q000502:physiology*; D058486:Receptors, Purinergic P2X7; D013154:Spleen / Q000166:cytology; D000095702:Polyether Toxins
D004996:Ethidium; D005456:Fluorescent Dyes; D008387:Marine Toxins; D035964:Oxocins; D018048:Receptors, Purinergic P2; D058486:Receptors, Purinergic P2X7; C546469:P2rx7 protein, mouse; C020394:maitotoxin; D000095702:Polyether Toxins